Research Study

Evaluation of Dupilumab in Patients With Persistent Asthma
Principal Investigator 
Mark FitzGerald

Overview

Body Locations and Systems 
Asthma
ClinicalTrials.gov# 
NCT02414854
Status 
Closed to Recruitment
Study Start/End 
Jul 16, 2015 to Jul 12, 2017
Locations 
Diamond Health Care Centre, Vancouver General Hospital
Name/Title 
Linda Hui, Research Nurse
Phone 
604-875-5697
Purpose of Study 

Primary Objective:

To evaluate the efficacy of dupilumab (SAR231893 [REGN668]) in patients with persistent asthma.

Secondary Objectives:

To evaluate the safety and tolerability of dupilumab. To evaluate the effect of dupilumab in improving patient-reported outcomes including health-related quality of life.

To evaluate dupilumab systemic exposure and incidence of antidrug antibodies.

Eligibility 

Visit Clinicaltrials.gov for more information. 

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific clinical research trials only. If you have specific questions which require clinical expertise, please call your primary care physician.